Grifols, S.A. (GIFLF)
OTCMKTS · Delayed Price · Currency is USD
14.00
+0.10 (0.72%)
Sep 25, 2025, 8:00 PM EDT
Grifols Market Cap
Grifols has a market cap or net worth of $8.51 billion as of September 29, 2025. Its market cap has increased by 21.14% in one year.
Market Cap
8.51B
Enterprise Value
21.94B
Revenue
8.74B
Ranking
n/a
PE Ratio
24.35
Stock Price
$14.00
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 931.51M to 8.51B, an increase of 813.10%. That is a compound annual growth rate of 12.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 8.51B | 44.62% |
| Dec 31, 2024 | 5.88B | -42.36% |
| Dec 29, 2023 | 10.20B | 45.60% |
| Dec 30, 2022 | 7.01B | -36.73% |
| Dec 30, 2021 | 11.08B | -36.06% |
| Dec 31, 2020 | 17.32B | -17.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 742.59M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 516.60M |
| Northwest Biotherapeutics | 385.85M |
| CytoDyn | 332.57M |
| American Oncology Network | 305.31M |
| Nika Pharmaceuticals | 301.74M |